U.S. market Closed. Opens in 2 days 1 hour 39 minutes

XTLB | XTL Biopharmaceuticals Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
RevenueN/A-459.00K1.47M28.00K69.00K52.00KN/AN/AN/AN/A2.37M938.00KN/AN/AN/A5.94M907.00K454.00K3.20M3.45MN/AN/AN/A
Cost of RevenueN/A1.00K1.00K1.00KN/AN/AN/AN/AN/AN/A741.00K380.00KN/AN/AN/AN/A110.00K54.00K2.80M3.30MN/AN/AN/A
Gross ProfitN/A-460.00K1.47M27.00K69.00K52.00KN/AN/AN/AN/A1.63M558.00KN/AN/AN/A5.94M797.00K400.00K400.00K153.00KN/AN/AN/A
Operating Expenses1.75K880.00K1.03M948.00K842.00K793.00K1.25M1.71M2.00M2.02M3.85M2.91M1.25M1.26M-2.57M15.53M26.53M16.45M13.00M16.93MN/AN/A15.12M
Selling, General & Admin734.00850.00K1.00M910.00K807.00K755.00K1.19M1.26M1.41M1.72M3.67M3.62M1.08M1.22M-2.43M5.14M5.58M5.58M5.46M4.13M3.10M3.64M3.00M
Research & Development31.0030.00K30.00K38.00K35.00K38.00K43.00K443.00K578.00K278.00K113.00K99.00K158.00K64.00KN/A10.39M20.95M10.87M7.54M12.79M11.10M13.16M11.05M
Other Operating ExpensesN/AN/AN/AN/AN/AN/A9.00K8.00K7.00K25.00K71.00K-802.00K12.00K-30.00K-139.00KN/AN/AN/AN/AN/AN/AN/A1.07M
Operating Income-765.00-880.00K-1.03M-948.00K-842.00K-793.00K-1.25M-2.56M-2.00M-2.02M-2.22M-2.36M-1.25M-1.26M2.57M-9.59M-25.73M-16.05M-12.60M-16.78M14.56M-17.71M-15.12M
Other Expenses / Income-1.02K-468.00K1.47M166.00K-505.00K3.70M465.00K16.00K-1.62M-97.00K-1.49M614.00K41.00K-1.00K-4.00K314.00K590.00K1.14M-1.34M352.00K-28.77M597.00KN/A
Before Tax Income-1.78K-1.35M435.00K-782.00K-1.35M2.99M-781.00K-2.54M-3.62M-2.12M-3.71M-1.74M-1.21M-1.26M2.56M-9.28M-25.14M-14.90M-13.94M-16.42M-14.21M-17.11MN/A
Income Tax Expenses-167.89K961.00K-1.47M-166.00K-69.00K-7.64MN/AN/AN/AN/AN/AN/AN/AN/A-23.00K-31.00K-206.00K227.00K78.00K49.00K78.00K27.00KN/A
Net Income-1.78K-2.31M1.90M-616.00K-1.28M2.99M-781.00K-2.54M-4.31M-2.53M-2.48M-1.39M-1.21M-1.26M2.59M-9.25M-24.94M-15.13M-14.02M-16.47M-14.29M-17.14M-12.67M
Interest ExpensesN/A468.00K21.00K17.00K29.00K80.00K29.00KN/AN/AN/A35.00K15.00K7.00K7.00K10.00K3.00K4.00KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding5.45M5.45M5.32M5.14M5.14M514.21M4.70M2.74M2.64M2.31M2.24M2.18M2.04M1.13M585.61K585.54K456.99K403.48K340.25K269.46K2.23M222.30K221.88K
Diluted Shares Outstanding5.45M5.45M6.16M5.14M5.14M514.21M4.70M2.74M2.64M2.31M2.24M2.18M2.04M1.13M587.70K585.54K456.99K403.48K3.37M2.75M2.23M222.30K221.88K
EBITDA-764.00-386.00K-2.50M-1.08M-268.00K-4.49M-751.00K-1.71M-1.99M-2.01M-2.13M-1.24M-1.15M-1.21M2.58M-9.23M-25.03M-14.66M-13.70M-16.11M15.36M-17.71M-15.12M
EBITDA Margin0.00%84.10%-170.26%-3,875.00%-388.41%-8,638.46%0.00%0.00%0.00%0.00%-89.83%-132.09%0.00%0.00%0.00%-155.47%-2,759.98%-3,229.52%-428.37%-466.27%0.00%0.00%0.00%
EBIT-169.68K-880.00K456.00K-765.00K-1.32M-4.57M-752.00K-2.54M-4.31M-2.53M-2.44M-1.38M-1.20M-1.25M2.57M-9.27M-25.14M-14.90M-13.94M-16.42M-14.21M-17.11M-12.67M
EBIT Margin0.00%191.72%31.11%-2,732.15%-1,910.14%-8,792.31%0.00%0.00%0.00%0.00%-103.04%-146.59%0.00%0.00%0.00%-156.13%-2,771.89%-3,283.04%-435.94%-475.51%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙